167 related articles for article (PubMed ID: 29315310)
1. Dysregulation of valvular interstitial cell let-7c, miR-17, miR-20a, and miR-30d in naturally occurring canine myxomatous mitral valve disease.
Yang VK; Tai AK; Huh TP; Meola DM; Juhr CM; Robinson NA; Hoffman AM
PLoS One; 2018; 13(1):e0188617. PubMed ID: 29315310
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
Tan K; Markby G; Muirhead R; Blake R; Bergeron L; Fici G; Summers K; Macrae V; Corcoran B
PLoS One; 2019; 14(8):e0221126. PubMed ID: 31415646
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis and abundance of Bcl-2 family and transforming growth factor β1 signaling proteins in canine myxomatous mitral valves.
Surachetpong S; Jiranantasak T; Rungsipipat A; Orton EC
J Vet Cardiol; 2013 Sep; 15(3):171-80. PubMed ID: 23816827
[TBL] [Abstract][Full Text] [Related]
4. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
[TBL] [Abstract][Full Text] [Related]
5. TGF-β-induced PI3K/AKT/mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease.
Tang Q; Markby GR; MacNair AJ; Tang K; Tkacz M; Parys M; Phadwal K; MacRae VE; Corcoran BM
Cell Prolif; 2023 Jun; 56(6):e13435. PubMed ID: 36869852
[TBL] [Abstract][Full Text] [Related]
6. Survival of activated myofibroblasts in canine myxomatous mitral valve disease and the role of apoptosis.
Blake RR; Markby GR; Culshaw GJ; Martinez-Pereira Y; Lu CC; Corcoran BM
Res Vet Sci; 2020 Feb; 128():99-106. PubMed ID: 31765842
[TBL] [Abstract][Full Text] [Related]
7. Defining the Role of the miR-145-KLF4-αSMA Axis in Mitral Valvular Interstitial Cell Activation in Myxomatous Mitral Valve Prolapse Using the Canine Model.
Yang VK; Moyer N; Zhou R; Carnevale SZ; Meola DM; Robinson SR; Li G; Das S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338749
[TBL] [Abstract][Full Text] [Related]
8. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.
Disatian S; Ehrhart EJ; Zimmerman S; Orton EC
J Heart Valve Dis; 2008 Jul; 17(4):402-11; discussion 412. PubMed ID: 18751470
[TBL] [Abstract][Full Text] [Related]
9. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.
Aupperle H; Disatian S
J Vet Cardiol; 2012 Mar; 14(1):59-71. PubMed ID: 22364722
[TBL] [Abstract][Full Text] [Related]
10. Morphological changes to endothelial and interstitial cells and to the extra-cellular matrix in canine myxomatous mitral valve disease (endocardiosis).
Han RI; Clark CH; Black A; French A; Culshaw GJ; Kempson SA; Corcoran BM
Vet J; 2013 Aug; 197(2):388-94. PubMed ID: 23465752
[TBL] [Abstract][Full Text] [Related]
11. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.
Li Q; Freeman LM; Rush JE; Laflamme DP
Int J Mol Sci; 2015 Jun; 16(6):14098-108. PubMed ID: 26101868
[TBL] [Abstract][Full Text] [Related]
12. Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model.
Yang VK; Loughran KA; Meola DM; Juhr CM; Thane KE; Davis AM; Hoffman AM
J Extracell Vesicles; 2017; 6(1):1350088. PubMed ID: 28804599
[TBL] [Abstract][Full Text] [Related]
13. Culture and characterisation of canine mitral valve interstitial and endothelial cells.
Liu MM; Flanagan TC; Lu CC; French AT; Argyle DJ; Corcoran BM
Vet J; 2015 Apr; 204(1):32-9. PubMed ID: 25747697
[TBL] [Abstract][Full Text] [Related]
14. Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation.
Sainger R; Grau JB; Branchetti E; Poggio P; Seefried WF; Field BC; Acker MA; Gorman RC; Gorman JH; Hargrove CW; Bavaria JE; Ferrari G
J Cell Physiol; 2012 Jun; 227(6):2595-604. PubMed ID: 22105615
[TBL] [Abstract][Full Text] [Related]
15. Alpha-smooth muscle actin and serotonin receptors 2A and 2B in dogs with myxomatous mitral valve disease.
Cremer SE; Moesgaard SG; Rasmussen CE; Zois NE; Falk T; Reimann MJ; Cirera S; Aupperle H; Oyama MA; Olsen LH
Res Vet Sci; 2015 Jun; 100():197-206. PubMed ID: 25843893
[TBL] [Abstract][Full Text] [Related]
16. Static and cyclic tensile strain induce myxomatous effector proteins and serotonin in canine mitral valves.
Lacerda CM; Maclea HB; Kisiday JD; Orton EC
J Vet Cardiol; 2012 Mar; 14(1):223-30. PubMed ID: 22364693
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
Lu CC; Liu MM; Culshaw G; French A; Corcoran B
J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration.
Jung S; Bohan A
Am J Vet Res; 2018 Feb; 79(2):163-169. PubMed ID: 29359980
[TBL] [Abstract][Full Text] [Related]
19. Structural and cellular changes in canine myxomatous mitral valve disease: an image analysis study.
Han RI; Black A; Culshaw G; French AT; Corcoran BM
J Heart Valve Dis; 2010 Jan; 19(1):60-70. PubMed ID: 20329491
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves.
Disatian S; Lacerda C; Orton EC
J Heart Valve Dis; 2010 Jan; 19(1):71-8. PubMed ID: 20329492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
